SEC Filing Timeline
8-KAug 11, 2026
Material agreement · Items 1.01,9.01
10-QAug 06, 2026
Quarterly report
8-KAug 06, 2026
Earnings release · Items 2.02,9.01
8-KJun 08, 2026
Material agreement · Items 1.01,9.01
424B5Jun 08, 2026
Prospectus / offering
8-KJun 04, 2026
Executive officer change · Items 5.02,5.07
10-QMay 14, 2026
Quarterly report
8-KMay 14, 2026
Earnings release · Items 2.02,9.01
8-KMay 01, 2026
Executive officer change · Items 5.02,7.01,9.01
DEF 14AApr 22, 2026
Proxy statement
S-3Mar 31, 2026
Shelf registration
Recent News (Finnhub)
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable C…
Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call - Slideshow
AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference